Residency · Tulsa, OK
Sponsored by Oklahoma State University Center for Health Sciences
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 350 citations · Brooke Esteves
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
The Lancet. Respiratory medicine · 2021 · 575 citations · Mousumi Som
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.
Journal of clinical lipidology · 2024 · 129 citations · Ryan Morgan
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.
Obesity pillars · 2024 · 62 citations · Ryan Morgan
Sex differences in pain along the neuraxis.
Neuropharmacology · 2022 · 65 citations · Zachary Griffin
Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 74 citations ·
Acute inflammatory profiles differ with sex and age after spinal cord injury.
Journal of neuroinflammation · 2021 · 78 citations · Katelyn Osborn
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2024 · 31 citations · Brooke Esteves